These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23745460)

  • 21. [Exercise is beneficial for patients with myositis. Both pharmaceuticals and physical activity should be included in the therapy of chronic rheumatic muscle inflammation].
    Lundberg IE; Alexanderson H; Arnardottir S; Borg K
    Lakartidningen; 2003 Sep; 100(36):2754-9. PubMed ID: 14558188
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical exercise as a treatment for adult and juvenile myositis.
    Alexanderson H
    J Intern Med; 2016 Jul; 280(1):75-96. PubMed ID: 26854121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
    Escalante A; Miller L; Beardmore TD
    J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
    Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
    Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory myopathies.
    Kingston WJ; Moxley RT
    Neurol Clin; 1988 Aug; 6(3):545-61. PubMed ID: 3065600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymyositis/dermatomyositis--clinical picture and treatment].
    Anić B; Cerovec M
    Reumatizam; 2012; 59(2):44-50. PubMed ID: 23745455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?
    Loell I; Lundberg IE
    J Intern Med; 2011 Mar; 269(3):243-57. PubMed ID: 21205023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammatory myopathies. Dermatomyositis, polymyositis, and inclusion body myositis].
    Selva O'Callaghan A; Trallero Araguás E
    Reumatol Clin; 2008 Sep; 4(5):197-206. PubMed ID: 21794530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of polymyositis and dermatomyositis].
    Morović-Vergles J; Mitrović J
    Reumatizam; 2012; 59(2):23-6. PubMed ID: 23745450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Insight into the training of patients with idiopathic inflammatory myopathy].
    Váncsa A
    Orv Hetil; 2016 Sep; 157(39):1557-1562. PubMed ID: 27667295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory myopathies: Part 1.
    Mastaglia FL; Ojeda VJ
    Ann Neurol; 1985 Mar; 17(3):215-27. PubMed ID: 2986525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
    Bertorini TE
    Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical activity and disablement in the idiopathic inflammatory myopathies.
    Harris-Love MO
    Curr Opin Rheumatol; 2003 Nov; 15(6):679-90. PubMed ID: 14569196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
    Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical spectrum of inflammatory myositis in South India--a ten year study.
    Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
    J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.